LeMaitre Vascular Company Profile (NASDAQ:LMAT)

About LeMaitre Vascular (NASDAQ:LMAT)

LeMaitre Vascular logoLeMaitre Vascular, Inc. is a provider of medical devices for the treatment of peripheral vascular disease. The Company develops, manufactures and markets medical devices and implants used primarily in the field of vascular surgery. It is engaged in the design, marketing, sales and technical support of medical devices and implants for the treatment of peripheral vascular disease industry segment. The Company's product lines include valvulotomes, balloon catheters, carotid shunts, biologic vascular patches, radiopaque marking tape, anastomotic clips, remote endarterectomy devices, laparoscopic cholecystectomy devices, prosthetic vascular grafts, biologic vascular grafts and powered phlebectomy devices. Its portfolio of peripheral vascular devices consists of brand name products that are used in arteries and veins outside of the heart, including the Expandable LeMaitre Valvulotome, the Pruitt F3 Carotid Shunt, VascuTape Radiopaque Tape and the XenoSure biologic patch.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Advanced Medical Equipment & Technology
  • Sub-Industry: N/A
  • Symbol: NASDAQ:LMAT
  • CUSIP: N/A
  • Web: www.lemaitre.com
  • Market Cap: $708.57 million
  • Outstanding Shares: 19,022,000
Average Prices:
  • 50 Day Moving Avg: $35.58
  • 200 Day Moving Avg: $29.96
  • 52 Week Range: $18.55 - $39.29
  • Trailing P/E Ratio: 53.21
  • Foreward P/E Ratio: 42.82
  • P/E Growth: 3.11
Sales & Book Value:
  • Annual Revenue: $96.4 million
  • Price / Sales: 7.35
  • Book Value: $5.20 per share
  • Price / Book: 7.16
  • Annual Dividend: $0.22
  • Dividend Yield: 0.6%
  • EBIDTA: $23.12 million
  • Net Margins: 14.19%
  • Return on Equity: 15.02%
  • Return on Assets: 12.97%
  • Current Ratio: 7.25%
  • Quick Ratio: 5.07%
  • Average Volume: 210,820 shs.
  • Beta: 0.67
  • Short Ratio: 2.66

Frequently Asked Questions for LeMaitre Vascular (NASDAQ:LMAT)

What is LeMaitre Vascular's stock symbol?

LeMaitre Vascular trades on the NASDAQ under the ticker symbol "LMAT."

How often does LeMaitre Vascular pay dividends? What is the dividend yield for LeMaitre Vascular?

LeMaitre Vascular declared a quarterly dividend on Friday, July 28th. Shareholders of record on Wednesday, August 23rd will be paid a dividend of $0.055 per share on Thursday, September 7th. This represents a $0.22 annualized dividend and a yield of 0.59%. The ex-dividend date is Monday, August 21st. View LeMaitre Vascular's Dividend History.

How will LeMaitre Vascular's stock buyback program work?

LeMaitre Vascular declared that its board has initiated a stock repurchase plan on Friday, July 28th 2017, which allows the company to repurchase $7,500,000.00 in outstanding shares, according to EventVestor. This repurchase authorization allows the company to buy up to 1.4% of its shares through open market purchases. Shares repurchase plans are typically a sign that the company's leadership believes its stock is undervalued.

How were LeMaitre Vascular's earnings last quarter?

LeMaitre Vascular, Inc. (NASDAQ:LMAT) issued its quarterly earnings data on Thursday, July, 27th. The company reported $0.23 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $0.17 by $0.06. The company earned $25.80 million during the quarter, compared to analyst estimates of $25.42 million. LeMaitre Vascular had a net margin of 14.19% and a return on equity of 15.02%. The firm's revenue for the quarter was up 15.2% compared to the same quarter last year. During the same period last year, the company earned $0.14 EPS. View LeMaitre Vascular's Earnings History.

When will LeMaitre Vascular make its next earnings announcement?

LeMaitre Vascular is scheduled to release their next quarterly earnings announcement on Tuesday, October, 24th 2017. View Earnings Estimates for LeMaitre Vascular.

What guidance has LeMaitre Vascular issued on next quarter's earnings?

LeMaitre Vascular updated its FY17 earnings guidance on Thursday, July, 27th. The company provided EPS guidance of $0.79 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.70. The company issued revenue guidance of $101.9 million, compared to the consensus revenue estimate of $100.61 million.LeMaitre Vascular also updated its Q3 guidance to $0.20 EPS.

Where is LeMaitre Vascular's stock going? Where will LeMaitre Vascular's stock price be in 2017?

6 brokerages have issued twelve-month price targets for LeMaitre Vascular's stock. Their forecasts range from $28.00 to $32.00. On average, they anticipate LeMaitre Vascular's share price to reach $30.00 in the next year. View Analyst Ratings for LeMaitre Vascular.

What are analysts saying about LeMaitre Vascular stock?

Here are some recent quotes from research analysts about LeMaitre Vascular stock:

  • 1. According to Zacks Investment Research, "LEMAITRE VASCULAR, INC. is a leading global provider of innovative devices for the treatment of peripheral vascular disease. LeMaitre develops, manufactures, and markets disposable and implantable vascular devices to address the needs of vascular surgeons and interventionalists. LeMaitre's diversified product portfolio consists of twelve well-known brand name products used in arteries and veins outside of the heart and are supported by a growing, specialized and highly trained organization of vascular sales professionals. LeMaitre Vascular offers a wide range of innovative products to vascular surgeons and interventionalists for improving procedure efficacy and minimizing patient recovery time. " (8/1/2017)
  • 2. Canaccord Genuity analysts commented, "We view this event as largely priced in, given the previous success in narcolepsy in a Phase II trial and a successful read-out from two Phase III trials in excessive sleepiness (ES) associated with obstructive sleep apnea (OSA). We currently model an 80% probability of approval and risk-adjusted sales of $558.9 million in 2026." (4/27/2017)

Who are some of LeMaitre Vascular's key competitors?

Who are LeMaitre Vascular's key executives?

LeMaitre Vascular's management team includes the folowing people:

  • George W. LeMaitre, Chairman of the Board, Chief Executive Officer
  • David B. Roberts, President, Director
  • Joseph P. Pellegrino Jr., Chief Financial Officer, Director
  • Peter R. Gebauer, President - International Operations
  • Trent G. Kamke, Senior Vice President - Operations
  • Cornelia W. LeMaitre, Vice President - Human Resources
  • Lawrence J. Jasinski, Independent Director
  • John J. O'Connor, Independent Director
  • John A. Roush, Independent Director
  • Michael H. Thomas, Independent Director

Who owns LeMaitre Vascular stock?

LeMaitre Vascular's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Dimensional Fund Advisors LP (5.15%), Vanguard Group Inc. (4.33%), AWM Investment Company Inc. (3.49%), Conestoga Capital Advisors LLC (3.00%), State Street Corp (2.01%) and Thomson Horstmann & Bryant Inc. (1.95%). Company insiders that own LeMaitre Vascular stock include Cornelia W Lemaitre, David B Roberts, George W Lemaitre, Joseph P Pellegrino, Jr, Lawrence J Jasinski, Michael T Wijas, Peter R Gebauer and Trent G Kamke. View Institutional Ownership Trends for LeMaitre Vascular.

Who sold LeMaitre Vascular stock? Who is selling LeMaitre Vascular stock?

LeMaitre Vascular's stock was sold by a variety of institutional investors in the last quarter, including AWM Investment Company Inc., William Blair Investment Management LLC, Cornerstone Capital Management Holdings LLC., Ameriprise Financial Inc., Rice Hall James & Associates LLC, Grandeur Peak Global Advisors LLC, Perkins Capital Management Inc. and Wells Fargo & Company MN. Company insiders that have sold LeMaitre Vascular stock in the last year include David B Roberts, George W Lemaitre, Lawrence J Jasinski, Michael T Wijas, Peter R Gebauer and Trent G Kamke. View Insider Buying and Selling for LeMaitre Vascular.

Who bought LeMaitre Vascular stock? Who is buying LeMaitre Vascular stock?

LeMaitre Vascular's stock was acquired by a variety of institutional investors in the last quarter, including Conestoga Capital Advisors LLC, Vanguard Group Inc., Janus Henderson Group PLC, Bank of New York Mellon Corp, Principal Financial Group Inc., Fiera Capital Corp, State Street Corp and Nationwide Fund Advisors. View Insider Buying and Selling for LeMaitre Vascular.

How do I buy LeMaitre Vascular stock?

Shares of LeMaitre Vascular can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is LeMaitre Vascular's stock price today?

One share of LeMaitre Vascular stock can currently be purchased for approximately $37.25.

MarketBeat Community Rating for LeMaitre Vascular (NASDAQ LMAT)
Community Ranking:  3.3 out of 5 (star star star)
Outperform Votes:  225 (Vote Outperform)
Underperform Votes:  111 (Vote Underperform)
Total Votes:  336
MarketBeat's community ratings are surveys of what our community members think about LeMaitre Vascular and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for LeMaitre Vascular (NASDAQ:LMAT) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 3 Hold Ratings, 3 Buy Ratings
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $30.00 (19.46% downside)

Analysts' Ratings History for LeMaitre Vascular (NASDAQ:LMAT)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
7/30/2017Stifel NicolausReiterated RatingBuy$29.00 -> $32.00HighView Rating Details
7/28/2017Benchmark Co.UpgradeHold -> BuyLowView Rating Details
7/10/2017Canaccord GenuityDowngradeBuy -> Hold$28.00HighView Rating Details
6/6/2017Craig HallumInitiated CoverageHold$31.00LowView Rating Details
3/21/2017First AnalysisInitiated CoverageOverweight -> Overweight$29.00LowView Rating Details
2/22/2017Barrington ResearchDowngradeOutperform -> Market PerformN/AView Rating Details
9/22/2016SidotiDowngradeBuy -> Neutral$23.00N/AView Rating Details
7/28/2016Brean CapitalBoost Price TargetBuy$17.50 -> $20.00N/AView Rating Details
5/3/2016Roth CapitalBoost Price TargetBuy$18.00 -> $18.50N/AView Rating Details
12/7/2015Dougherty & CoBoost Price TargetBuy$16.00 -> $19.00N/AView Rating Details
(Data available from 9/24/2015 forward)


Earnings History for LeMaitre Vascular (NASDAQ:LMAT)
Earnings by Quarter for LeMaitre Vascular (NASDAQ:LMAT)
Earnings History by Quarter for LeMaitre Vascular (NASDAQ LMAT)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/24/2017$0.20N/AView Earnings Details
7/27/2017Q2 2017$0.17$0.23$25.42 million$25.80 millionViewN/AView Earnings Details
5/4/2017Q1 2017$0.13$0.16$23.48 million$24.10 millionViewN/AView Earnings Details
2/21/2017Q4 2016$0.15$0.13$23.70 million$23.30 millionViewListenView Earnings Details
10/26/2016Q3$0.15$0.17$22.20 million$19.00 millionViewListenView Earnings Details
7/27/2016Q2$0.11$0.14$21.59 million$22.40 millionViewListenView Earnings Details
5/2/2016Q1$0.10$0.11$20.22 million$20.26 millionViewListenView Earnings Details
2/24/2016Q415$0.09$0.13$20.10 million$20.50 millionViewListenView Earnings Details
10/27/2015Q3$0.08$0.11$18.78 million$19.03 millionViewListenView Earnings Details
7/28/2015Q2$0.07$0.10$18.90 million$19.90 millionViewListenView Earnings Details
4/28/2015Q115$0.05$0.08$17.76 million$18.90 millionViewListenView Earnings Details
2/25/2015Q314$0.07$0.11$18.90 million$18.70 millionViewListenView Earnings Details
10/28/2014Q3$0.06$0.05$17.09 million$17.50 millionViewListenView Earnings Details
2/25/2014Q4$0.05$0.05ViewListenView Earnings Details
10/29/2013Q313$0.04$0.05$15.22 million$15.30 millionViewListenView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for LeMaitre Vascular (NASDAQ:LMAT)
2017 EPS Consensus Estimate: $0.67
2018 EPS Consensus Estimate: $0.79
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20173$0.13$0.14$0.13
Q2 20173$0.17$0.17$0.17
Q3 20173$0.17$0.20$0.18
Q4 20173$0.18$0.19$0.19
Q1 20182$0.19$0.19$0.19
Q2 20182$0.20$0.20$0.20
Q3 20181$0.20$0.20$0.20
Q4 20181$0.20$0.20$0.20
(Data provided by Zacks Investment Research)


Current Dividend Information for LeMaitre Vascular (NASDAQ:LMAT)
Most Recent Dividend:9/7/2017
Annual Dividend:$0.22
Dividend Yield:0.59%
Payout Ratio:31.88% (Trailing 12 Months of Earnings)
27.50% (Based on This Year's Estimates)
25.29% (Based on Next Year's Estimates)
Dividend Payments by Quarter for LeMaitre Vascular (NASDAQ:LMAT)

Dividend History by Quarter for LeMaitre Vascular (NASDAQ LMAT)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for LeMaitre Vascular (NASDAQ:LMAT)
Insider Ownership Percentage: 23.70%
Institutional Ownership Percentage: 66.32%
Insider Trades by Quarter for LeMaitre Vascular (NASDAQ:LMAT)
Institutional Ownership by Quarter for LeMaitre Vascular (NASDAQ:LMAT)
Insider Trades by Quarter for LeMaitre Vascular (NASDAQ:LMAT)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/30/2017David B RobertsInsiderSell26,683$36.67$978,465.61View SEC Filing  
8/30/2017George W LemaitreCEOSell15,000$37.13$556,950.00View SEC Filing  
8/29/2017George W LemaitreCEOSell15,000$36.72$550,800.00View SEC Filing  
8/28/2017George W LemaitreCEOSell30,000$36.43$1,092,900.00View SEC Filing  
8/25/2017George W LemaitreChairmanSell40,000$33.89$1,355,600.00View SEC Filing  
8/24/2017George W LemaitreCEOSell15,000$33.97$509,550.00View SEC Filing  
8/23/2017George W LemaitreCEOSell5,000$33.91$169,550.00View SEC Filing  
8/17/2017Lawrence J JasinskiDirectorSell2,030$34.23$69,486.90View SEC Filing  
8/11/2017George W LemaitreChairmanSell21,300$32.90$700,770.00View SEC Filing  
8/10/2017George W LemaitreCEOSell11,300$32.79$370,527.00View SEC Filing  
8/9/2017George W LemaitreChairmanSell30,000$33.65$1,009,500.00View SEC Filing  
8/8/2017George W LemaitreCEOSell10,000$34.02$340,200.00View SEC Filing  
8/7/2017George W LemaitreCEOSell10,000$33.62$336,200.00View SEC Filing  
8/7/2017Peter R GebauerInsiderSell6,224$33.85$210,682.40View SEC Filing  
8/4/2017David B RobertsInsiderSell48,317$33.12$1,600,259.04View SEC Filing  
8/3/2017George W LemaitreChairmanSell58,700$33.97$1,994,039.00View SEC Filing  
8/3/2017Peter R GebauerInsiderSell22,067$34.28$756,456.76View SEC Filing  
8/1/2017Lawrence J JasinskiDirectorSell6,500$34.47$224,055.00View SEC Filing  
6/1/2017Michael T WijasVPSell2,346$31.42$73,711.32View SEC Filing  
5/24/2017Trent G KamkeInsiderSell15,780$30.28$477,818.40View SEC Filing  
5/18/2017George W LemaitreChairmanSell21,225$30.11$639,084.75View SEC Filing  
5/11/2017David B RobertsInsiderSell39,531$30.37$1,200,556.47View SEC Filing  
5/10/2017George W LemaitreChairmanSell63,622$30.98$1,971,009.56View SEC Filing  
5/9/2017George W LemaitreCEOSell34,517$30.67$1,058,636.39View SEC Filing  
5/8/2017George W LemaitreCEOSell9,102$31.12$283,254.24View SEC Filing  
5/4/2017David B RobertsInsiderSell44,340$31.14$1,380,747.60View SEC Filing  
5/3/2017George W LemaitreChairmanSell87,342$32.35$2,825,513.70View SEC Filing  
3/10/2017David B RobertsInsiderSell5,900$22.44$132,396.00View SEC Filing  
3/1/2017George W LemaitreChairmanSell10,000$22.36$223,600.00View SEC Filing  
2/28/2017George W LemaitreCEOSell3,000$22.27$66,810.00View SEC Filing  
2/27/2017George W LemaitreCEOSell5,000$22.31$111,550.00View SEC Filing  
9/16/2016David B RobertsInsiderSell6,452$21.05$135,814.60View SEC Filing  
9/15/2016David B RobertsInsiderSell33,548$20.41$684,714.68View SEC Filing  
9/8/2016George W LemaitreChairmanSell30,000$20.48$614,400.00View SEC Filing  
9/7/2016David B RobertsInsiderSell20,000$20.07$401,400.00View SEC Filing  
9/2/2016George W LemaitreChairmanSell60,037$18.30$1,098,677.10View SEC Filing  
8/30/2016Peter R GebauerInsiderSell3,431$18.20$62,444.20View SEC Filing  
8/29/2016Peter R GebauerInsiderSell26,815$17.78$476,770.70View SEC Filing  
8/24/2016David B RobertsInsiderSell10,000$17.35$173,500.00View SEC Filing  
8/24/2016George W LemaitreCEOSell6,800$17.49$118,932.00View SEC Filing  
8/23/2016George W LemaitreCEOSell19,664$17.43$342,743.52View SEC Filing  
8/22/2016George W LemaitreCEOSell8,927$17.39$155,240.53View SEC Filing  
8/19/2016Cornelia W LemaitreDirectorSell5,000$17.15$85,750.00View SEC Filing  
8/18/2016Cornelia W LemaitreDirectorSell22,500$17.36$390,600.00View SEC Filing  
8/15/2016Cornelia W LemaitreDirectorSell22,500$17.36$390,600.00View SEC Filing  
8/15/2016George W LemaitreChairmanSell15,896$17.53$278,656.88View SEC Filing  
8/9/2016George W LemaitreChairmanSell5,460$17.41$95,058.60View SEC Filing  
8/9/2016Lawrence J JasinskiDirectorSell7,500$17.60$132,000.00View SEC Filing  
8/5/2016David B RobertsInsiderSell10,000$17.63$176,300.00View SEC Filing  
8/4/2016George W LemaitreChairmanSell4,540$17.65$80,131.00View SEC Filing  
7/28/2016Peter R GebauerInsiderSell30,000$16.47$494,100.00View SEC Filing  
6/8/2016George W LemaitreCEOSell19,189$15.01$288,026.89View SEC Filing  
6/7/2016George W LemaitreCEOSell9,100$15.02$136,682.00View SEC Filing  
6/6/2016George W LemaitreCEOSell900$15.06$13,554.00View SEC Filing  
6/6/2016Peter R GebauerInsiderSell6,310$14.96$94,397.60View SEC Filing  
6/3/2016Lawrence J JasinskiDirectorSell4,924$14.99$73,810.76View SEC Filing  
6/3/2016Trent G KamkeInsiderSell2,510$15.00$37,650.00View SEC Filing  
5/25/2016Lawrence J JasinskiDirectorSell6,326$15.30$96,787.80View SEC Filing  
5/25/2016Trent G KamkeInsiderSell1,524$15.25$23,241.00View SEC Filing  
5/23/2016Trent G KamkeInsiderSell16,465$15.02$247,304.30View SEC Filing  
5/18/2016George W LemaitreCEOSell2,944$15.23$44,837.12View SEC Filing  
5/17/2016Trent G KamkeInsiderSell2,400$15.51$37,224.00View SEC Filing  
5/16/2016George W LemaitreCEOSell1,740$15.49$26,952.60View SEC Filing  
5/13/2016George W LemaitreCEOSell7,451$15.45$115,117.95View SEC Filing  
5/9/2016George W LemaitreCEOSell110,189$16.17$1,781,756.13View SEC Filing  
5/6/2016David B RobertsDirectorSell17,064$15.89$271,146.96View SEC Filing  
5/5/2016Trent G KamkeInsiderSell3,327$16.10$53,564.70View SEC Filing  
4/18/2016David B RobertsDirectorSell1,766$16.10$28,432.60View SEC Filing  
4/4/2016David B RobertsDirectorSell17,444$15.99$278,929.56View SEC Filing  
2/25/2016David B RobertsDirectorSell2,690$15.91$42,797.90View SEC Filing  
1/14/2016David B. RobertsDirectorSell12,867$15.85$203,941.95View SEC Filing  
1/11/2016David B RobertsDirectorSell27,490$15.68$431,043.20View SEC Filing  
1/8/2016David B RobertsDirectorSell2,743$15.51$42,543.93View SEC Filing  
12/9/2015Joseph P. Pellegrino, Jr.CFOSell14,348$16.01$229,711.48View SEC Filing  
12/4/2015Peter R. GebauerinsiderSell12,816$15.53$199,032.48View SEC Filing  
12/1/2015Peter R. GebauerinsiderSell37,184$15.73$584,904.32View SEC Filing  
11/25/2015David B. RobertsDirectorSell10,000$15.96$159,600.00View SEC Filing  
11/24/2015Cornelia W LemaitreDirectorSell41,135$15.61$642,117.35View SEC Filing  
11/23/2015George W. LemaitreCEOSell65,052$15.63$1,016,762.76View SEC Filing  
11/23/2015Joseph P. Pellegrino, Jr.CFOSell45,840$15.57$713,728.80View SEC Filing  
11/23/2015Peter R. GebauerinsiderSell11,971$15.31$183,276.01View SEC Filing  
11/20/2015David B. RobertsDirectorSell10,000$14.73$147,300.00View SEC Filing  
11/20/2015Peter R. GebauerinsiderSell19,900$14.40$286,560.00View SEC Filing  
11/17/2015George W LemaitreCEOSell30,000$14.15$424,500.00View SEC Filing  
11/16/2015Lawrence J. JasinskiDirectorSell7,500$13.57$101,775.00View SEC Filing  
11/10/2015George W. LemaitreCEOSell57,844$13.80$798,247.20View SEC Filing  
11/9/2015George W. LemaitreCEOSell7,524$13.70$103,078.80View SEC Filing  
11/6/2015George W. LemaitreCEOSell39,000$13.83$539,370.00View SEC Filing  
10/30/2015George W. LemaitreCEOSell16,190$14.55$235,564.50View SEC Filing  
10/28/2015Peter R. GebauerinsiderSell44,315$13.97$619,080.55View SEC Filing  
9/25/2015Peter R. GebauerinsiderSell5,441$13.91$75,684.31View SEC Filing  
9/18/2015George W. LemaitreCEOSell46,391$14.37$666,638.67View SEC Filing  
9/17/2015George W. LemaitreCEOSell49,559$13.96$691,843.64View SEC Filing  
8/31/2015Peter R. GebauerinsiderSell10,465$13.49$141,172.85View SEC Filing  
8/27/2015George W. LemaitreCEOSell28,700$13.66$392,042.00View SEC Filing  
8/26/2015Peter R. GebauerinsiderSell15,978$13.53$216,182.34View SEC Filing  
8/20/2015David B RobertsDirectorSell12,000$13.58$162,960.00View SEC Filing  
8/19/2015Peter R. GebauerinsiderSell4,022$14.24$57,273.28View SEC Filing  
8/13/2015George W LemaitreCEOSell33,059$13.41$443,321.19View SEC Filing  
5/19/2015Peter R GebauerInsiderSell10,000$10.12$101,200.00View SEC Filing  
5/18/2015George W LemaitreCEOSell20,132$10.01$201,521.32View SEC Filing  
5/11/2015David B RobertsDirectorSell15,000$10.31$154,650.00View SEC Filing  
5/7/2015George W LemaitreCEOSell70,984$9.72$689,964.48View SEC Filing  
5/6/2015David B RobertsDirectorSell11,000$9.27$101,970.00View SEC Filing  
4/29/2015Peter R GebauerInsiderSell15,332$8.99$137,834.68View SEC Filing  
4/16/2015Cornelia W LemaitreDirectorSell17,100$8.55$146,205.00View SEC Filing  
4/14/2015Cornelia W LemaitreDirectorSell6,707$8.42$56,472.94View SEC Filing  
3/31/2015Cornelia W LemaitreDirectorSell819$8.37$6,855.03View SEC Filing  
3/30/2015Cornelia W LemaitreDirectorSell31$8.36$259.16View SEC Filing  
3/25/2015Cornelia W LemaitreDirectorSell3,678$8.33$30,637.74View SEC Filing  
3/24/2015Cornelia W LemaitreDirectorSell3,373$8.33$28,097.09View SEC Filing  
3/23/2015Cornelia W LemaitreDirectorSell26,026$8.21$213,673.46View SEC Filing  
3/18/2015Cornelia W LemaitreDirectorSell5,601$8.03$44,976.03View SEC Filing  
3/10/2015Peter R GebauerInsiderSell10,000$8.15$81,500.00View SEC Filing  
3/9/2015Peter R GebauerInsiderSell7,200$8.15$58,680.00View SEC Filing  
3/6/2015Cornelia W LemaitreDirectorSell6,065$8.20$49,733.00View SEC Filing  
3/3/2015David B RobertsDirectorSell12,000$7.65$91,800.00View SEC Filing  
1/29/2015Peter R GebauerInsiderSell16,919$7.91$133,829.29View SEC Filing  
1/26/2015George W LemaitreCEOSell3,486$7.85$27,365.10View SEC Filing  
1/26/2015Peter R GebauerInsiderSell1,800$7.90$14,220.00View SEC Filing  
1/5/2015George W LemaitreCEOSell18,447$7.74$142,779.78View SEC Filing  
1/2/2015David B RobertsDirectorSell7,000$7.31$51,170.00View SEC Filing  
12/30/2014George W LemaitreCEOSell18,067$7.58$136,947.86View SEC Filing  
12/29/2014George W LemaitreCEOSell5,058$7.59$38,390.22View SEC Filing  
12/26/2014George W LemaitreCEOSell6,693$7.53$50,398.29View SEC Filing  
12/24/2014George W LemaitreCEOSell2,900$7.60$22,040.00View SEC Filing  
12/10/2014George W LemaitreCEOSell1,117$7.40$8,265.80View SEC Filing  
12/9/2014David B RobertsDirectorSell3,000$7.36$22,080.00View SEC Filing  
12/9/2014George W LemaitreCEOSell1,794$7.40$13,275.60View SEC Filing  
11/28/2014George W LemaitreCEOSell42,641$7.40$315,543.40View SEC Filing  
11/25/2014George W LemaitreCEOSell613$7.30$4,474.90View SEC Filing  
11/13/2014Trent G KamkeInsiderSell1,100$7.15$7,865.00View SEC Filing  
11/5/2014George W LemaitreCEOSell28,286$7.07$199,982.02View SEC Filing  
10/31/2014David B RobertsPresidentSell3,500$7.03$24,605.00View SEC Filing  
10/31/2014George W LemaitreCEOSell23,758$7.14$169,632.12View SEC Filing  
9/8/2014George W LemaitreCEOSell29,966$7.10$212,758.60View SEC Filing  
9/4/2014Lawrence J JasinskiDirectorSell3,750$7.14$26,775.00View SEC Filing  
6/25/2014Cornelia W LemaitreDirectorSell4,700$8.32$39,104.00View SEC Filing  
5/7/2014David RobertsPresidentSell3,000$7.95$23,850.00View SEC Filing  
3/7/2014Russell HaysDirectorSell15,000$8.07$121,050.00View SEC Filing  
3/6/2014Cornelia LemaitreDirectorSell6,950$8.15$56,642.50View SEC Filing  
3/6/2014Trent KamkeInsiderSell1,278$8.18$10,454.04View SEC Filing  
3/4/2014Cornelia LemaitreDirectorSell12,845$8.29$106,485.05View SEC Filing  
1/23/2014Cornelia LemaitreDirectorSell3,900$8.24$32,136.00View SEC Filing  
11/1/2013David B RobertsDirectorSell2,000$7.96$15,920.00View SEC Filing  
10/31/2013Cornelia W LemaitreDirectorSell20,000$7.88$157,600.00View SEC Filing  
10/25/2013Cornelia W LemaitreDirectorSell20,000$7.38$147,600.00View SEC Filing  
9/5/2013Joseph P Pellegrino JrCFOSell25,000$6.86$171,500.00View SEC Filing  
9/3/2013David B RobertsDirectorSell6,500$6.90$44,850.00View SEC Filing  
8/14/2013Cornelia W LemaitreDirectorSell7,500$7.00$52,500.00View SEC Filing  
8/12/2013Trent G KamkeInsiderSell2,000$6.90$13,800.00View SEC Filing  
8/8/2013Trent G KamkeInsiderSell2,000$6.83$13,660.00View SEC Filing  
8/2/2013Russell D HaysDirectorSell15,000$6.78$101,700.00View SEC Filing  
7/30/2013David B RobertsDirectorSell12,403$6.85$84,960.55View SEC Filing  
7/29/2013Cornelia W LemaitreDirectorSell2,500$7.00$17,500.00View SEC Filing  
7/26/2013David B RobertsDirectorSell9,100$6.77$61,607.00View SEC Filing  
6/24/2013David B RobertsDirectorSell2,100$6.75$14,175.00View SEC Filing  
6/5/2013Robert V LindenVPSell9,383$6.45$60,520.35View SEC Filing  
5/30/2013Cornelia W LemaitreDirectorSell10,000$6.50$65,000.00View SEC Filing  
11/27/2012Cornelia W LemaitreDirectorSell2,699$6.25$16,868.75View SEC Filing  
8/10/2012George D LemaitreDirectorSell5,862$6.45$37,809.90View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for LeMaitre Vascular (NASDAQ:LMAT)
Latest Headlines for LeMaitre Vascular (NASDAQ:LMAT)
nasdaq.com logo5 MedTech Stocks to Pick for Stellar Returns - Nasdaq
www.nasdaq.com - September 19 at 1:01 AM
finance.yahoo.com logoETFs with exposure to LeMaitre Vascular, Inc. : September 14, 2017
finance.yahoo.com - September 15 at 6:06 AM
finance.yahoo.com logoLeMaitre Vascular, Inc. :LMAT-US: Earnings Analysis: Q2, 2017 By the Numbers : September 13, 2017
finance.yahoo.com - September 14 at 7:15 AM
americanbankingnews.com logo Brokerages Anticipate LeMaitre Vascular, Inc. (LMAT) Will Post Quarterly Sales of $25.42 Million
www.americanbankingnews.com - September 7 at 11:30 AM
americanbankingnews.com logoLeMaitre Vascular, Inc. (LMAT) Given Average Rating of "Hold" by Brokerages
www.americanbankingnews.com - September 6 at 10:42 PM
nasdaq.com logoForget Abbott, Buy These 4 High-Growth MedTech Stocks Instead - Nasdaq
www.nasdaq.com - September 6 at 9:43 PM
globenewswire.com logoLeMaitre Vascular to Present at Upcoming Investor Conferences - GlobeNewswire (press release)
globenewswire.com - September 5 at 9:04 PM
americanbankingnews.com logoLeMaitre Vascular, Inc. (LMAT) Insider Sells $978,465.61 in Stock
www.americanbankingnews.com - September 1 at 10:24 PM
americanbankingnews.com logoLeMaitre Vascular, Inc. (LMAT) CEO George W. Lemaitre Sells 15,000 Shares
www.americanbankingnews.com - August 30 at 10:20 PM
americanbankingnews.com logoInsider Selling: LeMaitre Vascular, Inc. (LMAT) CEO Sells 15,000 Shares of Stock
www.americanbankingnews.com - August 30 at 10:20 PM
americanbankingnews.com logoLeMaitre Vascular, Inc. (LMAT) CEO Sells $1,092,900.00 in Stock
www.americanbankingnews.com - August 30 at 10:20 PM
americanbankingnews.com logoLeMaitre Vascular, Inc. (LMAT) Cut to "Hold" at BidaskClub
www.americanbankingnews.com - August 28 at 8:10 PM
americanbankingnews.com logoLeMaitre Vascular, Inc. (LMAT) CEO George W. Lemaitre Sells 5,000 Shares
www.americanbankingnews.com - August 25 at 8:32 PM
americanbankingnews.com logoGeorge W. Lemaitre Sells 40,000 Shares of LeMaitre Vascular, Inc. (LMAT) Stock
www.americanbankingnews.com - August 25 at 7:44 PM
nasdaq.com logoWhy LeMaitre Vascular (LMAT) Could Be Positioned for a Surge - Nasdaq
www.nasdaq.com - August 22 at 3:33 PM
americanbankingnews.com logoLeMaitre Vascular, Inc. (LMAT) Director Sells $69,486.90 in Stock
www.americanbankingnews.com - August 21 at 8:10 PM
zacks.com logoWhy LeMaitre Vascular (LMAT) Could Be Positioned for a Surge
www.zacks.com - August 21 at 8:26 AM
americanbankingnews.com logo$25.42 Million in Sales Expected for LeMaitre Vascular, Inc. (LMAT) This Quarter
www.americanbankingnews.com - August 19 at 5:22 AM
nasdaq.com logoLeMaitre Vascular, Inc. (LMAT) Ex-Dividend Date Scheduled for August 21, 2017 - Nasdaq
www.nasdaq.com - August 19 at 1:44 AM
thestreet.com logoReminder - LeMaitre Vascular (LMAT) Goes Ex-Dividend Soon
www.thestreet.com - August 18 at 8:43 PM
americanbankingnews.com logoZacks: Analysts Expect LeMaitre Vascular, Inc. (LMAT) Will Announce Earnings of $0.20 Per Share
www.americanbankingnews.com - August 17 at 2:12 PM
finance.yahoo.com logoLeMaitre Vascular, Inc. – Value Analysis (NASDAQ:LMAT) : August 14, 2017
finance.yahoo.com - August 15 at 1:04 AM
americanbankingnews.com logoLeMaitre Vascular, Inc. (LMAT) Given Average Rating of "Buy" by Brokerages
www.americanbankingnews.com - August 12 at 10:50 PM
americanbankingnews.com logoInsider Selling: LeMaitre Vascular, Inc. (LMAT) CEO Sells 11,300 Shares of Stock
www.americanbankingnews.com - August 11 at 7:54 PM
americanbankingnews.com logoLeMaitre Vascular, Inc. (LMAT) Chairman Sells $700,770.00 in Stock
www.americanbankingnews.com - August 11 at 7:52 PM
americanbankingnews.com logoLeMaitre Vascular, Inc. (LMAT) Insider Peter R. Gebauer Sells 6,224 Shares
www.americanbankingnews.com - August 9 at 9:04 PM
americanbankingnews.com logoInsider Selling: LeMaitre Vascular, Inc. (NASDAQ:LMAT) CEO Sells 10,000 Shares of Stock
www.americanbankingnews.com - August 9 at 8:46 PM
americanbankingnews.com logoLeMaitre Vascular, Inc. (NASDAQ:LMAT) CEO George W. Lemaitre Sells 10,000 Shares
www.americanbankingnews.com - August 9 at 8:46 PM
americanbankingnews.com logoInsider Selling: LeMaitre Vascular, Inc. (NASDAQ:LMAT) Chairman Sells 30,000 Shares of Stock
www.americanbankingnews.com - August 9 at 7:52 PM
americanbankingnews.com logoDavid B. Roberts Sells 48,317 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT) Stock
www.americanbankingnews.com - August 8 at 7:24 PM
americanbankingnews.com logoPeter R. Gebauer Sells 22,067 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT) Stock
www.americanbankingnews.com - August 4 at 10:26 AM
americanbankingnews.com logoLawrence J. Jasinski Sells 6,500 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT) Stock
www.americanbankingnews.com - August 3 at 10:38 PM
americanbankingnews.com logoInsider Selling: LeMaitre Vascular, Inc. (NASDAQ:LMAT) Chairman Sells 58,700 Shares of Stock
www.americanbankingnews.com - August 3 at 10:38 PM
finance.yahoo.com logoLeMaitre Vascular, Inc. breached its 50 day moving average in a Bullish Manner : LMAT-US : July 31, 2017
finance.yahoo.com - August 2 at 3:10 AM
americanbankingnews.com logoLeMaitre Vascular (NASDAQ:LMAT) versus Pacific Biosciences of California (PACB) Head to Head Contrast
www.americanbankingnews.com - July 31 at 12:25 PM
americanbankingnews.com logoEquities Analysts Offer Predictions for LeMaitre Vascular, Inc.'s Q3 2017 Earnings (LMAT)
www.americanbankingnews.com - July 31 at 7:45 AM
americanbankingnews.com logoLeMaitre Vascular, Inc. (LMAT) Given Buy Rating at Stifel Nicolaus
www.americanbankingnews.com - July 30 at 10:26 PM
americanbankingnews.com logo$0.20 Earnings Per Share Expected for LeMaitre Vascular, Inc. (NASDAQ:LMAT) This Quarter
www.americanbankingnews.com - July 30 at 10:24 AM
seekingalpha.com logoLeMaitre Vascular's (LMAT) CEO George LeMaitre on Q2 2017 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - July 30 at 12:30 AM
americanbankingnews.com logoLeMaitre Vascular, Inc. (NASDAQ:LMAT) Posts Earnings Results, Beats Expectations By $0.06 EPS
www.americanbankingnews.com - July 29 at 3:26 PM
finance.yahoo.com logoEdited Transcript of LMAT earnings conference call or presentation 27-Jul-17 9:00pm GMT
finance.yahoo.com - July 29 at 2:33 AM
finance.yahoo.com logoLeMaitre tops Street 2Q forecasts
finance.yahoo.com - July 29 at 2:33 AM
americanbankingnews.com logoLeMaitre Vascular, Inc. (NASDAQ:LMAT) Upgraded by Benchmark Co. to Buy
www.americanbankingnews.com - July 28 at 5:21 PM
americanbankingnews.com logoLeMaitre Vascular, Inc. (LMAT) Declares Quarterly Dividend of $0.06
www.americanbankingnews.com - July 28 at 4:28 PM
americanbankingnews.com logoStock Repurchase Program Announced by LeMaitre Vascular (NASDAQ:LMAT) Board
www.americanbankingnews.com - July 28 at 11:20 AM
finance.yahoo.com logoInvestor Network: LeMaitre Vascular, Inc. to Host Earnings Call
finance.yahoo.com - July 28 at 2:18 AM
finance.yahoo.com logoLeMaitre Q2 2017 Record Sales $25.8 mm (+15%), Record EPS $0.23 (+69%)
finance.yahoo.com - July 28 at 2:17 AM
americanbankingnews.com logoLeMaitre Vascular, Inc. (NASDAQ:LMAT) Updates Q3 Earnings Guidance
www.americanbankingnews.com - July 27 at 10:31 PM
americanbankingnews.com logoLeMaitre Vascular, Inc. (LMAT) Issues FY17 Earnings Guidance
www.americanbankingnews.com - July 27 at 10:31 PM
finance.yahoo.com logoETFs with exposure to LeMaitre Vascular, Inc. : July 24, 2017
finance.yahoo.com - July 25 at 2:54 AM



LeMaitre Vascular (LMAT) Chart for Sunday, September, 24, 2017

This page was last updated on 9/24/2017 by MarketBeat.com Staff